0002133041-26-000001.txt : 20260513 0002133041-26-000001.hdr.sgml : 20260513 20260513164217 ACCESSION NUMBER: 0002133041-26-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260513 DATE AS OF CHANGE: 20260513 EFFECTIVENESS DATE: 20260513 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Pillar Therapeutics, Inc. CENTRAL INDEX KEY: 0002133041 ORGANIZATION NAME: EIN: 414750175 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-583919 FILM NUMBER: 26974132 BUSINESS ADDRESS: STREET 1: 200 BERKELEY STREET, 18TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 720-566-4255 MAIL ADDRESS: STREET 1: 200 BERKELEY STREET, 18TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 D 1 primary_doc.xml X0708 D LIVE 0002133041 Pillar Therapeutics, Inc. 200 BERKELEY STREET, 18TH FLOOR BOSTON MA MASSACHUSETTS 02116 720-566-4255 DELAWARE None None Corporation true 2026 COSMAS GIALLOURAKISV c/o 200 BERKELEY STREET, 18TH FLOOR BOSTON MA MASSACHUSETTS 02116 Executive Officer Director Promoter TESS CAMERON c/o 200 BERKELEY STREET, 18TH FLOOR BOSTON MA MASSACHUSETTS 02116 Director JENNA HEBERT c/o 200 BERKELEY STREET, 18TH FLOOR BOSTON MA MASSACHUSETTS 02116 Director AMANDA CREEDON c/o 200 BERKELEY STREET, 18TH FLOOR BOSTON MA MASSACHUSETTS 02116 Executive Officer Biotechnology Decline to Disclose 06b false 2026-04-14 false true false 0 25000000 14000000 11000000 false 2 0 0 0 false Pillar Therapeutics, Inc. /s/ Cosmas Giallourakis Cosmas Giallourakis Chief Executive Officer 2026-05-13